Resistance to Treatment for Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia expert Dr. Alessandra Ferrajoli, from The University of Texas MD Anderson Cancer Center, talks about the issue of resistance in treating CLL. Dr. Ferrajoli explains which new therapies—and new combinations of existing therapies—are showing promise, especially when resistance is detected and addressed early. Watch now to learn more from a CLL expert.

Key Takeaways

  • Resistance can be an issue in treating CLL, but new therapies offer hope and additional treatment options.
This article was originally published February 7, 2020 and most recently updated November 18, 2020.
© 2024 HealthCentral LLC. All rights reserved.

More on Chronic Lymphocytic Leukemia